Delivery Order SPE2DB20D3103-SPE2DB22FN5K1

Award Date 5/4/22
Potential Completion Date 5/5/22
Potential Value $5.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,263.60 firm fixed-price delivery order is for the supply of ALPHAGAN P 0.15% eye drops in 5ml containers. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,244.59 firm-fixed-price delivery order is for the supply of ALPHAGAN P 0.15% eye drops, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,656.23 firm-fixed-price delivery order is for Alphagan P 0.15% eye drops, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This single-award IDC serves as the...
This federal contract award is a delivery order (SPE2DB24D1021|SPE2DB25FERPL) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,947.93 firm-fixed-price contract is for the supply of ALPHAGAN P 0.15% eye drops (4566188423) with a completion date of October 24, 2024. The award is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ALPHAGAN P 0.15% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, with a ceiling value of $3,052.45, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ALPHAGAN P 0.1% eye drops. The $1,517.15 firm fixed-price delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,281.62 firm-fixed-price delivery order is for the supply of ALPHAGAN P 0.15% eye drops, a medication used to treat glaucoma and high eye pressure. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,100.46 firm fixed-price delivery order is for the supply of ALPHAGAN P 0.1% eye drops, a prescription medication used to treat glaucoma and high eye pressure. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB20D3101|SPE2DB22FJ5A5, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.59 contract is for the delivery of ALPHAGAN P 0.1% eye drops in 5 mL packages. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,649.73 firm-fixed-price delivery order is for the supply of Alphagan P 0.15% eye drops, a pharmaceutical product. The contract has an ultimate completion date of February 29, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN5K1
    Delivery Order

This federal contract award, identified as SPE2DB20D3103 and SPE2DB22FN5K1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,694.95 firm fixed-price delivery order is for the supply of ALPHAGAN P 0.15% eye drops, a prescription medication.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a wide range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and Department of Veterans Affairs. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:01 AM